Filing Details

Accession Number:
0001209191-21-020468
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-15 16:29:25
Reporting Period:
2021-03-11
Accepted Time:
2021-03-15 16:29:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX Biological Products, (No Disgnostic Substances) (2836) 464233385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813796 Paul Sauer C/O Vaxcyte, Inc.
353 Hatch Drive
Foster City CA 94404
Svp Process Dev, Manufacturing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-11 2,500 $1.79 80,399 No 4 M Direct
Common Stock Disposition 2021-03-11 2,500 $25.00 77,899 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-03-11 2,500 $0.00 2,500 $1.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,426 2027-05-17 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.